A major new long-term study offers another compelling message for the Exercise Oncology movement: strength matters—not only for quality of life, but potentially for survival.
Researchers followed 147,374 adults for up to 30 years, repeatedly measuring resistance training and aerobic activity patterns over time. Unlike many earlier studies that measured exercise only once, this study tracked behavior longitudinally—making the findings especially meaningful for long-term health and survivorship discussions.
The Headline Finding: More Is Not Always Better
Compared with individuals performing no resistance training:
- 90–119 minutes/week of resistance training was associated with:
- 13% lower all-cause mortality
- 19% lower cardiovascular mortality
- 27% lower neurological disease mortality
Interestingly, benefits appeared to plateau above approximately 120 minutes/week, suggesting that moderate, sustainable resistance exercise may provide the greatest return.
For cancer mortality, the relationship was different:
- Lower resistance training volumes (1–59 minutes/week) were associated with reduced cancer mortality.
- Higher volumes did not appear to further improve cancer-specific outcomes in this cohort.
Why This Matters for Exercise Oncology
This study was not conducted specifically in cancer patients, but its implications for Exercise Oncology are difficult to ignore.
Cancer survivors frequently face:
- Accelerated muscle loss (sarcopenia)
- Treatment-related fatigue
- Functional decline
- Cardiometabolic disease
- Reduced physiologic reserve
- Long-term neurologic and cognitive concerns
Resistance training directly addresses many of these vulnerabilities.
Exercise Oncology has historically emphasized aerobic activity—and appropriately so—but this paper supports a more balanced message:
Muscle preservation and muscle building may deserve equal attention.
For cancer survivors, resistance training may help:
- Preserve lean body mass during and after treatment
- Improve treatment tolerance
- Support Metabolic Health
- Improve independence and physical function
- Counteract frailty and aging acceleration
- Potentially contribute to improved long-term outcomes
The Most Powerful Combination: Aerobic + Strength Training
One of the strongest findings was not resistance training alone.
The lowest mortality risk occurred when participants combined aerobic activity with resistance training. Participants performing both types of exercise experienced substantially greater reductions in mortality risk than either modality alone.
This aligns closely with a central principle of CancerFitness.org:
Exercise is not one thing. The biology of cancer survivorship likely responds best to a combination of cardiovascular conditioning, muscle strengthening, mobility, and long-term consistency.
What Cancer Patients and Survivors Can Do Today
If medically cleared:
✓ Add 2–3 resistance sessions per week
✓ Prioritize major muscle groups
✓ Combine with regular aerobic movement
✓ Focus on consistency—not extreme training volumes
✓ Track strength and body composition over time
Exercise should increasingly be viewed not simply as rehabilitation—but as an important component of survivorship care.
CancerFitness.org Call-to-Action
Cancer survivors deserve more than advice to “stay active.”
They deserve access to structured Exercise Oncology Programs that include resistance training, aerobic conditioning, body composition assessment, and long-term survivorship support.
The future of cancer care should not only aim to extend life—but to build the strength needed to live it.
Reference: Long-term resistance training with all-cause and cause-specific mortality: assessing dose-response and joint associations with aerobic physical activity. Yiwen Zhang, Dong Hoon Lee, Leandro F M Rezende, Yuan Ma, Edward Giovannucci. Br J SportsMed 2026;0:1–10. doi:10.1136/bjsports-2025-110503
